scispace - formally typeset
A

Audes D. M. Feitosa

Researcher at Federal University of Pernambuco

Publications -  57
Citations -  1789

Audes D. M. Feitosa is an academic researcher from Federal University of Pernambuco. The author has contributed to research in topics: Medicine & Blood pressure. The author has an hindex of 10, co-authored 40 publications receiving 1134 citations. Previous affiliations of Audes D. M. Feitosa include Universidade de Pernambuco & Ministry of Agriculture.

Papers
More filters
Journal ArticleDOI

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

Matthew T. Roe, +1038 more
TL;DR: Among patients with unstable angina or myocardial infarction without ST-segment elevation, prasugrel did not significantly reduce the frequency of the primary end point, as compared with clopidogrel, and similar risks of bleeding were observed.
Journal ArticleDOI

Diretrizes Brasileiras de Hipertensão Arterial – 2020

Weimar Kunz Sebba Barroso, +97 more
TL;DR: The Brazilian Guidelines of Hypertension -2020 as mentioned in this paper have been published for the first time in the year 2020, and are based on the definition, epidemiology, and primary prevention.
Journal ArticleDOI

Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019.

Dalton Bertolim Précoma, +75 more
TL;DR: The Brazilian Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019 updates the strategies that address classical risk factors and discusses new concepts, such as the need to gather knowledge about emerging risk factors, as well as additional strategies, like the use of vaccines.
Journal ArticleDOI

Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial.

TL;DR: The DARE-19 trial as discussed by the authors was a randomized, double-blind, placebo-controlled trial of patients hospitalised with COVID-19 and with at least one cardiometabolic risk factor (i.e., hypertension, type 2 diabetes, atherosclerotic cardiovascular disease, heart failure, and chronic kidney disease).